Drug profile · INN
finerenone
KERENDIA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
finerenone (KERENDIA) is an FDA-listed pharmaceutical active ingredient. Associated with Bayer Australia Ltd. Route of administration: film coated. Current US regulatory status: approved.
Key facts
INN finerenone
Brand KERENDIA
Route FILM COATED
Formulation TABLET
ATC code C09
Originator Bayer Australia Ltd
Frequently asked questions
What is finerenone?
finerenone (KERENDIA) is an FDA-listed pharmaceutical active ingredient. Associated with Bayer Australia Ltd. Route of administration: film coated. Current US regulatory status: approved.
What is the brand name for finerenone?
KERENDIA is a marketed brand name for finerenone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of finerenone?
finerenone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.